Evidence map›Paper›PMID 27596252›Full record

ArticleBMC cardiovascular disorders2016

Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes.

Isabel Gonçalves, Andreas Edsfeldt, Helen M Colhoun, Angela C Shore, Carlo Palombo, Andrea Natali, Gunilla Nordin Fredrikson, Harry Björkbacka, Maria Wigren, Eva Bengtsson and 17 more

Open access · goldAbstract read
In one paragraph

Article in BMC cardiovascular disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 6 institutions in 3 countries.

Isabel GonçalvesDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Andreas EdsfeldtDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Helen M ColhounMedical Research Institute, University of Dundee, Dundee, UK.
Angela C ShoreDiabetes and Vascular Medicine, NIHR Exeter Clinical Research Facility and University of Exeter Medical School, Exeter, UK.
Carlo PalomboDepartment of Surgical, Medical, Molecular Pathology, and Critical Area Medicine, Pisa, Italy.
Andrea NataliDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Gunilla Nordin FredriksonDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Harry BjörkbackaDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Maria WigrenDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Eva BengtssonDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Gerd ÖstlingDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Kunihiko AizawaDiabetes and Vascular Medicine, NIHR Exeter Clinical Research Facility and University of Exeter Medical School, Exeter, UK.
Francesco CasanovaDiabetes and Vascular Medicine, NIHR Exeter Clinical Research Facility and University of Exeter Medical School, Exeter, UK.
Margaretha PerssonDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Kim GoodingDiabetes and Vascular Medicine, NIHR Exeter Clinical Research Facility and University of Exeter Medical School, Exeter, UK.
Phil GatesDiabetes and Vascular Medicine, NIHR Exeter Clinical Research Facility and University of Exeter Medical School, Exeter, UK.
Faisel KhanMedical Research Institute, University of Dundee, Dundee, UK.
Helen C LookerMedical Research Institute, University of Dundee, Dundee, UK.
Fiona AdamsMedical Research Institute, University of Dundee, Dundee, UK.
Jill BelchMedical Research Institute, University of Dundee, Dundee, UK.
Silvia PinnolaDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Elena VenturiDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Michaela KozakovaDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Li-Ming GanAstraZeneca, Cardiovascular and Metabolic Diseases, Mölndal, Sweden.
Volker SchneckeAstraZeneca, Cardiovascular and Metabolic Diseases, Mölndal, Sweden.
Jan NilssonDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden. jan.nilsson@med.lu.se.
SUMMIT consortium
Lund University · SEUniversity of Dundee · GBUniversity of Pisa · ITNIHR Exeter Clinical Research Facility · GBAstraZeneca (Sweden) · SEUniversity of Exeter · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundActivation of the renin-angiotensin-aldosterone-system (RAAS) has been proposed to contribute to development of vascular complications in type 2 diabetes (T2D). The aim of the present study was to determine if plasma renin levels are associated with the severity of vascular changes in subjects with and without T2D.

methodsRenin was analyzed by the Proximity Extension Assay in subjects with (n = 985) and without (n = 515) T2D participating in the SUMMIT (SUrrogate markers for Micro- and Macro-vascular hard endpoints for Innovative diabetes Tools) study and in 205 carotid endarterectomy patients. Vascular changes were assessed by determining ankle-brachial pressure index (ABPI), carotid intima-media thickness (IMT), carotid plaque area, pulse wave velocity (PWV) and the reactivity hyperemia index (RHI).

resultsPlasma renin was elevated in subjects with T2D and demonstrated risk factor-independent association with prevalent cardiovascular disease both in subjects with and without T2D. Renin levels increased with age, body mass index, HbA1c and correlated inversely with HDL. Subjects with T2D had more severe carotid disease, increased arterial stiffness, and impaired endothelial function. Risk factor-independent associations between renin and APBI, bulb IMT, carotid plaque area were observed in both T2D and non-T2D subjects. These associations were independent of treatment with RAAS inhibitors. Only weak associations existed between plasma renin and the expression of pro-inflammatory and fibrous components in plaques from 205 endarterectomy patients.

conclusionsOur findings provide clinical evidence for associations between systemic RAAS activation and atherosclerotic burden and suggest that this association is of particular importance in T2D.

Indexed as

AgedAnkle Brachial IndexBiomarkersCarotid ArteriesCarotid Artery DiseasesCarotid Intima-Media ThicknessDiabetes Mellitus, Type 2Endothelium, VascularFemaleFollow-Up StudiesHumansMalePlaque, AtheroscleroticPrognosisReninRetrospective StudiesBiomarkersReninArterial stiffnessAtherosclerosisEndothelial dysfunctionReninType 2 diabetes

Identifiers

PMID27596252
PMCPMC5011869
OpenAlexW2511949453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.